BRASILIA/RIO DE JANEIRO, (Reuters) - Brazil’s Fiocruz biomedical center will request authorization for emergency use of the COVID-19 vaccine developed by AstraZeneca PLC and Oxford University by next Wednesday, its president, Nísia Trindade, said yesterday.
The article Brazil’s Fiocruz to seek emergency use of British COVID-19 vaccine appeared first on Stabroek News.
